Bulletin
Investor Alert

New York Markets Close in:

Medexus Pharmaceuticals Inc.

TSE: CA:MDP

GO

Quotes are delayed by 15 min

Feb 1, 2023, 11:00 a.m.

MDP
/zigman2/quotes/208555543/delayed

$

1.86

Change

-0.04 -2.11%

Volume

Volume 3,756

Quotes are delayed by 15 min

/zigman2/quotes/208555543/delayed

Previous close

$ 1.90

$ 1.86

Change

-0.04 -2.11%

Day low

Day high

$1.84

$1.89

Open

52 week low

52 week high

$0.88

$3.45

Open

Michael C. Pine

Michael Pine is Senior VP-Business Development & Strategy at Medexus Pharmaceuticals, Inc.

He previously was VP, Head-Corporate Development & Licensing at Aralez Pharmaceuticals, Inc. and Senior VP-Business Development & Licensing at Lupin Pharmaceuticals, Inc.

Mr. Pine received an MBA from Columbia Business School and an undergraduate degree from Cornell University.

Transactions

Date Shares Transaction Value
08/19/2021 500   1,440
08/19/2021 500   1,440
06/21/2021 500   3,615
06/21/2021 500   3,615
03/31/2021 1,000   6,220
03/31/2021 1,000   6,220
09/21/2020 0   0
09/21/2020 0   0

Officers and Executives

Mr. Kenneth d’Entremont
Chief Executive Officer & Director
Mr. Richard Labelle
VP-Allergy, Pediatric & OTC Portfolios
Mr. Marcel Konrad
Chief Financial Officer
Mr. Ian C. Wildgoose Brown
Secretary & General Counsel
Mr. Peter A. van der Velden
Chairman
Ms. Adele M. Gulfo
Independent Director
Mr. Michael Peter Mueller
Independent Director
Mr. Benoit Gravel
Independent Director
Mr. Stephen Nelson
Independent Director
Link to MarketWatch's Slice.